KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Invested Capital (2017 - 2025)

Sarepta Therapeutics has reported Return on Invested Capital over the past 9 years, most recently at 0.65% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.65% for Q4 2025, down 73.0% from a year ago — trailing twelve months through Dec 2025 was 0.65% (down 73.0% YoY), and the annual figure for FY2025 was 0.43%, down 51.0%.
  • Return on Invested Capital for Q4 2025 was 0.65% at Sarepta Therapeutics, down from 0.1% in the prior quarter.
  • Over the last five years, Return on Invested Capital for SRPT hit a ceiling of 0.08% in Q4 2024 and a floor of 0.65% in Q4 2025.
  • Median Return on Invested Capital over the past 5 years was 0.26% (2023), compared with a mean of 0.24%.
  • Biggest five-year swings in Return on Invested Capital: rose 29bps in 2024 and later tumbled -73bps in 2025.
  • Sarepta Therapeutics' Return on Invested Capital stood at 0.37% in 2021, then grew by 23bps to 0.28% in 2022, then soared by 51bps to 0.14% in 2023, then soared by 155bps to 0.08% in 2024, then crashed by -947bps to 0.65% in 2025.
  • The last three reported values for Return on Invested Capital were 0.65% (Q4 2025), 0.1% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.